Literature DB >> 17720099

Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients.

Kirsten L Johansen1, Glenn M Chertow.   

Abstract

OBJECTIVE: Our objective was to determine the extent to which chronic kidney disease mineral bone disorder (CKD-MBD) is associated with health-related quality of life among incident dialysis patients.
DESIGN: This study's design was a cross-sectional analysis.
SETTING: This was part of the United States Renal Data System Dialysis Morbidity and Mortality Study (DMMS), Wave 2. PATIENTS: The patients comprised 2590 adult participants in DMMS Wave 2, for whom quality of life and laboratory data were available.
METHODS: We stratified patients according to their serum concentrations of phosphorus, calcium, and parathyroid hormone (PTH), and compared health-related quality of life as a function of these indicators in analyses adjusted for demographic, clinical, and other laboratory variables. MAIN OUTCOME MEASURES: Main outcome measures included Physical Component Summary (PCS) and Mental Component Summary (MCS) scores, and the Symptom score of the Kidney Disease Quality of Life.
RESULTS: Both high and low serum phosphorus concentrations were associated with lower PCS scores (-1.25 to -1.48 points compared with the reference category), as was low PTH (-1.49 points). Low serum phosphorus was associated with more severe symptoms of kidney disease (-3.88 points), but there were no associations between high phosphorus or either extreme of PTH and the Symptom score. Serum calcium concentration and the calcium x phosphorus product were unassociated with PCS or Symptom scores. There were no associations among phosphorus, calcium, or PTH and MCS. Analyses simultaneously controlling for serum phosphorus, calcium, and PTH showed similar results.
CONCLUSION: High and low serum phosphorus and low PTH are associated with slightly poorer self-reported physical functioning. Clinical trials will be necessary to determine whether and to what extent improvement in health status may occur with the correction of selected disorders of mineral metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720099      PMCID: PMC2737501          DOI: 10.1053/j.jrn.2007.06.005

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  22 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Nutritional status affects quality of life in Hemodialysis (HEMO) Study patients at baseline.

Authors:  Johanna T Dwyer; Brett Larive; June Leung; Michael Rocco; Jerrilynn D Burrowes; Wm Cameron Chumlea; Anne Frydrych; John W Kusek; Leigh Uhlin
Journal:  J Ren Nutr       Date:  2002-10       Impact factor: 3.655

3.  Quality-of-life evaluation using Short Form 36: comparison in hemodialysis and peritoneal dialysis patients.

Authors:  J A Diaz-Buxo; E G Lowrie; N L Lew; H Zhang; J M Lazarus
Journal:  Am J Kidney Dis       Date:  2000-02       Impact factor: 8.860

4.  Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Antonio Alberto Lopes; Jennifer L Bragg-Gresham; Sudtida Satayathum; Keith McCullough; Trinh Pifer; David A Goodkin; Donna L Mapes; Eric W Young; Robert A Wolfe; Philip J Held; Friedrich K Port
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

5.  Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients.

Authors:  Edmund G Lowrie; Roberta Braun Curtin; Nancy LePain; Dorian Schatell
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

6.  Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study.

Authors:  Mark Unruh; Robert Benz; Tom Greene; Guofen Yan; Srinivasan Beddhu; Maria DeVita; Johanna T Dwyer; Paul L Kimmel; John W Kusek; Alice Martin; Josephine Rehm-McGillicuddy; Brendan P Teehan; Klemens B Meyer
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

Review 7.  Pathophysiology of vascular calcification in chronic kidney disease.

Authors:  Sharon M Moe; Neal X Chen
Journal:  Circ Res       Date:  2004-09-17       Impact factor: 17.367

Review 8.  Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia.

Authors:  Markus Ketteler; Christoph Wanner; Thomas Metzger; Philipp Bongartz; Ralf Westenfeld; Ulrich Gladziwa; Leon J Schurgers; Cees Vermeer; Willi Jahnen-Dechent; Jürgen Floege
Journal:  Kidney Int Suppl       Date:  2003-05       Impact factor: 10.545

9.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Authors:  Geoffrey A Block; Preston S Klassen; J Michael Lazarus; Norma Ofsthun; Edmund G Lowrie; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

10.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

View more
  7 in total

1.  Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial.

Authors:  George A Kaysen; Brett Larive; Patricia Painter; Alexander Craig; Robert M Lindsay; Michael V Rocco; John T Daugirdas; Gerald Schulman; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2011-01       Impact factor: 8.860

2.  Bone mineral density and parathyroid function in patients on maintenance hemodialysis.

Authors:  Cs Ambrus; Cs Almasi; K Berta; Gy Deak; A Marton; M Zs Molnar; Zs Nemeth; Cs Horvath; P Lakatos; M Szathmari; I Mucsi
Journal:  Int Urol Nephrol       Date:  2010-01-21       Impact factor: 2.370

3.  Bone mineral metabolism and subsequent hospitalization with poor quality of life in dialysis patients.

Authors:  Zohreh Rostami; Mahboobeh Sadat Hosseini; Mahboob Lessan Pezeshki; Farrokh Heidari; Behzad Einollahi
Journal:  Nephrourol Mon       Date:  2014-01-20

4.  Quality of life, clinical outcome, personality and coping in chronic hemodialysis patients.

Authors:  Giuseppina D'Onofrio; Mariadelina Simeoni; Paolo Rizza; Mariarita Caroleo; Maria Capria; Giovanni Mazzitello; Tiziana Sacco; Elena Mazzuca; Maria Teresa Panzino; Annamaria Cerantonio; Cristina Segura-Garcia; Michele Andreucci; Pasquale De Fazio; Giorgio Fuiano
Journal:  Ren Fail       Date:  2016-10-25       Impact factor: 2.606

5.  Effect of CKD-MBD phenotype on health-related quality of life in patients receiving maintenance hemodialysis: A cross-sectional study.

Authors:  Laimin Luo; Qinkai Chen
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

6.  Association of anemia and mineral and bone disorder with health-related quality of life in Asian pre-dialysis patients.

Authors:  Hwee-Lin Wee; Benjamin Jun Jie Seng; Jia Jia Lee; Kok Joon Chong; Pallavi Tyagi; Anantharaman Vathsala; Priscilla How
Journal:  Health Qual Life Outcomes       Date:  2016-06-24       Impact factor: 3.186

7.  Frailty Severity and Hospitalization After Dialysis Initiation.

Authors:  David Clark; Kara Matheson; Benjamin West; Amanda Vinson; Kenneth West; Arsh Jain; Kenneth Rockwood; Karthik Tennankore
Journal:  Can J Kidney Health Dis       Date:  2021-06-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.